Pain in Inflammatory Joint Diseases
Recruiting · NCT06718569 · Observational (researchers observe without assigning treatment) · Lead sponsor: Diakonhjemmet Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Biological or targeted synthetic DMARD
What this trial is about
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- All patients who initiate or switch biological or targeted synthetic DMARDs
Exclusion criteria
- None
Where it is running
2 locations listed.
- Diakonhjemmet Hospital - Oslo, Norway
- Diakonhjemmet Hospital - Oslo, Norway